ArticleJournal of experimental & clinical cancer research : CR2022

ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development.

Liwei Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.